相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection
O. Reynard et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Knockdown of Ebola Virus VP24 Impairs Viral Nucleocapsid Assembly and Prevents Virus Replication
Mathieu Mateo et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Genomic RNA Editing and Its Impact on Ebola Virus Adaptation During Serial Passages in Cell Culture and Infection of Guinea Pigs
Valentina A. Volchkova et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Ebolavirus VP24 Binding to Karyopherins Is Required for Inhibition of Interferon Signaling
Mathieu Mateo et al.
JOURNAL OF VIROLOGY (2010)
Genetic factors of Ebola virus virulence in guinea pigs
Ekaterina Subbotina et al.
VIRUS RESEARCH (2010)
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
Thomas W. Geisbert et al.
VACCINE (2008)
Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
Thomas W. Geisbert et al.
PLOS PATHOGENS (2008)
Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin a proteins with activated STAT1
St. Patrick Reid et al.
JOURNAL OF VIROLOGY (2007)
Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome
Shinji Watanabe et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Regions in Ebola virus VP24 that are important for nucleocapsid formation
Takeshi Noda et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
How Ebola and Marburg viruses battle the immune system
Mansour Mohamadzadeh et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Effective post-exposure treatment of Ebola infection
Heinz Feldmann et al.
PLOS PATHOGENS (2007)
Molecular determinants of Ebola virus virulence in mice
Hideki Ebihara et al.
PLOS PATHOGENS (2006)
Ebola virus VP24 binds karyopherin α1 and blocks STAT1 nuclear accumulation
St. Patrick Reid et al.
JOURNAL OF VIROLOGY (2006)
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
Nancy J. Sullivan et al.
PLOS MEDICINE (2006)
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
SM Jones et al.
NATURE MEDICINE (2005)
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques - Evidence that dendritic cells are early and sustained targets of infection
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Pathogenesis of Ebola hemorrhagic fever in primate models - Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein
Y Huang et al.
MOLECULAR CELL (2002)
The role of the Type I interferon response in the resistance of mice to filovirus infection
M Bray
JOURNAL OF GENERAL VIROLOGY (2001)
Early immune responses accompanying human asymptomatic Ebola infections
EM Leroy et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Recovery of infectious Ebola virus from complementary DNA:: RNA editing of the GP gene and viral cytotoxicity
VE Volchkov et al.
SCIENCE (2001)
Molecular characterization of guinea pig-adapted variants of Ebola virus
VE Volchkov et al.
VIROLOGY (2000)
Human asymptomatic Ebola infection and strong inflammatory response
EM Leroy et al.
LANCET (2000)
分享论文
